TTP is aiming to provide a centralized life science infrastructure to promote scientific interaction where translational scientist and clinicians can work collaboratively, building upon existing strength and the unique resources of the university and the State of Texas for the discovery and development of therapeutic probes. Our representative collaborators are;
GCC IDDD (Gulf Coast Consortia Innovative Drug Discovery and Development)
TxSACT (Texas Screening Alliance for Cancer Therapeutics)
SGC-UNC (Structural Genomics Consortium at University of North Carolina)
Academic Drug Discovery Consortium (ADDC)
